2012Xinxueguan kangfu yixue zazhiRequires access

Maintenance of sinus rhythm by irbesartan combined with amiodarone after cardioversion in patients with paroxysmal atrial fibrillation

Lin Xiao-feng

Open publisher page 0 citations

Abstract

Objective:To study maintenance of sinus rhythm by irbesartan combined with amiodarone after cardioversion in patients with paroxysmal atrial fibrillation(PAF) and its influence on left atrial diameter.Methods:A total of 89 PAF patients were divided into amiodarone treatment group(n=44,only received amiodarone) and combination therapy group(n=45,received amiodarone and irbesartan).All patients were followed up for 12 months.Changes of maintenance rate of sinus rhythm and left atrial diameter before and after treatment were observed and compared between the two groups.Results:Compared with amiodarone group after 12 months,there was significant increase in maintenance rate of sinus rhythm(64.3% vs.81.4%) and significant decrease in left atrial diameter [(40.12±10.6) mm vs.(34.10±10.11) mm] in combination therapy group,P0.05 both.Conclusion:Maintenance of sinus rhythm by irbesartan combined with amiodarone after cardioversion in patients with paroxysmal atrial fibrillation is significantly better than that of single amiodarone treatment,and irbesartan combined with amiodarone significantly inhibits left atrial enlargement without significant adverse reactions.

About this research paper

What this paper is about

Objective:To study maintenance of sinus rhythm by irbesartan combined with amiodarone after cardioversion in patients with paroxysmal atrial fibrillation(PAF) and its influence on left atrial diameter.Methods:A total of 89 PAF patients were divided into amiodarone treatment group(n=44,only received amiodarone) and combination therapy group(n=45,received amiodarone and irbesartan).All patients were followed up for 12 months.Changes of maintenance rate of sinus rhythm and left atrial diameter before and after treatment were observed and compared between the two groups.Results:Compared with amiodarone group after 12 months,there was significant increase in maintenance rate of sinus rhythm(64.3% vs.81.4%) and significant decrease in left atrial diameter [(40.12±10.6) mm vs.(34.10±10.11) mm] in combination therapy group,P0.05 both.Conclusion:Maintenance of sinus rhythm by irbesartan combined with amiodarone after cardioversion in patients with paroxysmal atrial fibrillation is significantly better than that of single amiodarone treatment,and irbesartan combined with amiodarone significantly inhibits left atrial enlargement without significant adverse reactions.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective:To study maintenance of sinus rhythm by irbesartan combined with amiodarone after cardioversion in patients with paroxysmal atrial fibrillation(PAF) and its influence on left atrial diameter.Methods:A total of 89 PAF patients were divided into amiodarone treatment group(n=44,only received amiodarone) and combination therapy group(n=45,received amiodarone and irbesartan).All patients were followed up for 12 months.Changes of maintenance rate of sinus rhythm and left atrial diameter before and after treatment were observed and compared between the two groups.Results:Compared with amiodarone group after 12 months,there was significant increase in maintenance rate of sinus rhythm(64.3% vs.81.4%) and significant decrease in left atrial diameter [(40.12±10.6) mm vs.(34.10±10.11) mm] in combination therapy group,P0.05 both.Conclusion:Maintenance of sinus rhythm by irbesartan combined with amiodarone after cardioversion in patients with paroxysmal atrial fibrillation is significantly better than that of single amiodarone treatment,and irbesartan combined with amiodarone significantly inhibits left atrial enlargement without significant adverse reactions.

Key concepts: Amiodarone, Medicine, Irbesartan, Sinus rhythm, Atrial fibrillation, Cardioversion, Cardiology, Internal medicine

Related papers

Back to paper searchBrowse research topicsOriginal source
Maintenance of sinus rhythm by irbesartan combined with amiodarone after cardioversion in patients with paroxysmal atrial fibrillation — Research Paper | ScholarLens